Roche Ends Polyphor Antibiotics Pact | Chemical & Engineering News
Volume 93 Issue 48 | p. 27 | Concentrates
Issue Date: December 7, 2015

Roche Ends Polyphor Antibiotics Pact

Department: Business
Keywords: pharmaceuticals, biotech, antibiotics

Roche has dissolved an antibiotics pact with the Swiss biotech firm Polyphor. The companies joined forces in 2013 to develop POL7080, a macrocycle antibiotic currently in Phase II tests to treat hospital-acquired bacterial infections caused by Pseudomonas aeruginosa. Polyphor says it plans to continue the trials. The partnership was one of the first established by Roche as it reentered the antibiotics field; it has since sealed partnerships with Meiji Seika Pharma, Discuva, and Spero Therapeutics.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment